It is reassuring to note that once a decision to treat has been made people wait on average 5 days to receive treatment. However we continue to see an increasing number of eligible cancer referrals and our priority is to ensure these people receive cancer diagnosis and treatment safely and based on their clinical urgency.

While suspected cancer patients are always prioritised there are capacity pressures on diagnostic services. This is why we have published a £70m Endoscopy and Urology Diagnostic Recovery & Renewal plan, which includes a commitment to develop a network of Urology Diagnostic Hubs which will help reduce waiting times for people with cancer.

We have also provided three permanent CT scanners to support core capacity within Boards, including a mobile CT pod. In addition, one further mobile CT and seven mobile MRI scanners are being used across multiple NHS Boards to provide additional capacity with plans underway to further increase activity.

The Scottish Government remains committed to improving the A96. This is despite stark challenges we face as a result of the severe budgetary restrictions imposed by the UK Government including an almost 9% cut in our capital budget.

The current plan is to fully dual the route and as part of this process we are undertaking a transparent, evidence-based review of the programme.

The significant interest in the review’s initial consultation, with nearly 4,600 responses, generated 11,000 options to improve the corridor. It is only right that it has taken more time than originally anticipated, in order to properly examine and fully appraise these.

It is expected that the draft outcomes from the Review will be consulted on in the coming months, before a final decision can be reached.

The Scottish Government does not hold the information requested.

Public Health Scotland publish official statistics on how long patients waited for their first cancer treatment at

Cancer waiting times - 1 October to 31 December 2023 - Cancer waiting times - Publications - Public Health Scotland and on ongoing waits for key diagnostic tests at Diagnostic waiting times - Waits for key diagnostic tests 27 February 2024 - NHS waiting times - diagnostics - Publications - Public Health Scotland

The regulation for the pricing and supply of medicines is reserved to the UK Government. Scottish Government officials worked closely with their counterparts in the UK Government during the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) negotiations with the pharmaceutical industry, however, the devolved administrations were not included in the formal negotiations.

Commitments made on medicines and pharmaceutical manufacturing sustainability in the 2024 VPAG can be found in section 7.11 to 7.14 here: 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (publishing.service.gov.uk) .

The Scottish Government pathways report , published in November 2021, provides a full breakdown of how many beds there are in the Highland and Island region by local authority. Public Health Scotland latest report , published on 19 December, details how many beds have become available since then as a result of the Residential Rehabilitation Rapid Capacity Programme (RRRCP).

As part of the second round of the RRRCP, funding has been awarded to create 6 additional beds at CrossReach’s Beechwood House in Inverness and 1 additional bed at the Maxie Richards Foundation in Tignabruaich. This funding will deliver an additional 25 placements over the course of the year for the Highlands and Islands.

The Scottish Government has not consulted the Scottish Information Commissioner, as the role of the Scottish Information Commissioner is limited by law to promoting and enforcing Scotland's freedom of information (FOI) law.

Excessively long waits are, of course, unacceptable. We are working hard to drive down the longest waits, which have been exacerbated by the impacts of the global pandemic, to ensure all people receive the treatment they need as soon as possible.

The commitments set out in our £1bn NHS Recovery Plan support an increase in inpatient, day-case, and outpatient activity through the implementation of sustainable improvements and new models of care, and NHS Scotland’s Centre for Sustainable Delivery (CfSD) is working with Health Boards to ensure that they are able to continually identify new ways to increase capacity, and to respond to demand through service innovation and redesign.

CfSD programmes have developed strong clinically-led Specialty Delivery Groups (SDG), including one for General Surgery which is currently focused on Inguinal Hernia, Biliary Disease, and Emergency Laparoscopic and Laparotomy Scottish Audit (ELLSA) pathways.

SDGs promote multidisciplinary team working, and support local adoption of service improvement programmes and have supported several new and innovative pathway developments, many of which are now being successfully scaled up across Scotland, including Active Clinical Referral Triage (ACRT).

The NHS Golden Jubilee also continues to provide Health Boards, including NHS Lanarkshire, with capacity for key elective services, such as General Surgery, with patients treated on the basis of their clinical priority and length of wait.

Cancer remains a national priority, within the Scottish Government and across NHS Scotland, with urgent suspicion of cancer referrals continuing to be prioritised. NHS Grampian provided a 62 day performance improvement plan with an associated £973,764 funding from Scottish Government in 2023-24. Officials continue to work with NHS Grampian to ensure there is sustained focus locally to deliver these plans.

We are committed to reducing inpatient and day-case waiting lists by an estimated 100,000 patients over the next three years, backed by planned investment of an extra £100 million annually, subject to the annual Scottish Budget process, we will work closely with NHS boards and stakeholders on a number of key actions which will see patients treated as quickly as possible.

An initial investment of £30 million will now be funded as part of our on-going management of this and will target reductions to the national backlogs that built up throughout the pandemic, including orthopaedics treatments, diagnostics for cancer referrals and patients with the longest waits. This will enable NHS Scotland to maximise capacity, including theatre capacity, build greater resilience and deliver year-on-year reductions in the number of patients who have waited too long for treatment.

Updated guidance on the use of mobile phone technologies in schools will be published in the coming weeks. The current guidance to education authorities and schools on this issue remains available from Guidance on Developing Policies to Promote the Safe and Responsible Use of Mobile Technology in Schools (www.gov.scot).

We will publish recommendations of the SBA Task and Finish Group to date by the end of July 2024.